Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866952 · ClinicalTrials.gov registry record
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
A clinical trial of Dyspnea and Post-Acute COVID-19, sponsored by Tufts Medical Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05866952: Recruiting study of Dyspnea and Post-Acute COVID-19, sponsored by Tufts Medical Center.
NCT05866952 is a study of Dyspnea and Post-Acute COVID-19 that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 40 participants, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05866952, a study of Dyspnea and Post-Acute COVID-19, is actively recruiting participants, sponsored by Tufts Medical Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Computed Tomography of the Chest
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2026-12-31 |
What NCT05866952 shows while recruiting
NCT05866952 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (87% lower).
The record links to 4 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography of the Chest is the first listed.
NCT05866952 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05866952 about?
NCT05866952 is a clinical study titled "Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection". Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations
What is the current status of trial NCT05866952?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-06-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05866952 study?
This clinical trial studies the following conditions: Dyspnea, Post-Acute COVID-19, Post COVID-19 Condition, Post Viral Fatigue.
What interventions are being tested in trial NCT05866952?
The interventions under investigation include: Computed Tomography of the Chest (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05866952?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05866952 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05866952's enrollment target sits among peer trials
40 16th of 23 higher than 8 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
-
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI